AETHLON MEDICAL INC
For the period ended Mar 31, 2024. Filed Jun 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 27, 2024
AEMD$5.47+3.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
| Years Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| REVENUES: | ||
| Government contract and grant revenue | $– | $574,245 |
| Total revenues | – | 574,245 |
| OPERATING COSTS AND EXPENSES | ||
| Professional fees | 3,526,926 | 3,548,028 |
| Payroll and related expenses | 5,206,451 | 4,443,552 |
| General and administrative | 3,903,191 | 4,481,303 |
| Total operating expenses | 12,636,568 | 12,472,883 |
| OPERATING LOSS | (12,636,568) | (11,898,638) |
| OTHER EXPENSE (INCOME) | ||
| Loss on dissolution of subsidiary | – | 142,121 |
| Interest income and other | (428,394) | (10,973) |
| Other expense (income) | (428,394) | 131,148 |
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | (12,208,174) | (12,029,786) |
| Basic and diluted net loss per share attributable to common stockholders | $(4.86) | $(5.86) |
| Weighted average number of common shares outstanding - basic and diluted | 2,512,774 | 2,053,744 |
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | (12,208,174) | (12,029,786) |
| OTHER COMPREHENSIVE LOSS | (799) | (6,141) |
| COMPREHENSIVE LOSS | $(12,208,973) | $(12,035,927) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.